JPWO2021110923A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021110923A5
JPWO2021110923A5 JP2022533500A JP2022533500A JPWO2021110923A5 JP WO2021110923 A5 JPWO2021110923 A5 JP WO2021110923A5 JP 2022533500 A JP2022533500 A JP 2022533500A JP 2022533500 A JP2022533500 A JP 2022533500A JP WO2021110923 A5 JPWO2021110923 A5 JP WO2021110923A5
Authority
JP
Japan
Prior art keywords
care product
dental care
dental
self
gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022533500A
Other languages
Japanese (ja)
Other versions
JP2023505248A (en
Publication date
Priority claimed from EP19213470.8A external-priority patent/EP3831360A1/en
Application filed filed Critical
Publication of JP2023505248A publication Critical patent/JP2023505248A/en
Publication of JPWO2021110923A5 publication Critical patent/JPWO2021110923A5/ja
Pending legal-status Critical Current

Links

Claims (15)

(i)配列番号21の配列を含む自己組織化ペプチド、ここで該自己組織化ペプチドは、組織化した形態で歯科治療製品中に本質的に存在する、および
(ii)薬学的に許容される基剤
を含む歯科治療製品であって、ここで、該歯科治療製品は、チューインガム、ソフトチュー、タフィー、ゼラチンガム、チューインガム、チューインガム、トローチ、またはタブレットからなる群から選択される本質的に固体の製品であり、
該歯科治療製品は、研磨性でない、歯科治療製品。
(i) a self-assembling peptide comprising the sequence of SEQ ID NO: 21, wherein the self-assembling peptide is essentially present in the dental care product in an assembled form, and (ii) is pharmaceutically acceptable. A dental care product comprising a base, wherein the dental care product comprises an essentially solid base selected from the group consisting of chewing gum, soft chews, toffee, gelatin gum, chewing gum, chewing gum, troches, or tablets. product,
The dental care product is a non-abrasive dental care product.
組織化した形態の自己組織化ペプチドが薬学的に許容される基剤中に埋め込まれ、これは、好ましくは、高分子、可塑剤および/または樹脂を含む群から選択される成分を含むガムベースである、請求項1に記載の歯科治療製品。 The self-assembling peptide in organized form is embedded in a pharmaceutically acceptable base, which is preferably a gum base comprising components selected from the group comprising polymers, plasticizers and/or resins. The dental treatment product of claim 1. 前記ガムベースが、
a)ブタジエン-スチレンゴム、イソブチレン-イソプレン共重合体、パラフィン、石油系(way)、石油ワックス合成、ポリイソブチレンポリ酢酸ビニル、ポリイソブタジエンおよびイソブチレン-イソプレン共重合体、ポリブテン、ポリブタジエンおよびポリイソブチレンなどの低分子量エラストマー、ポリ酢酸ビニル、ポリエチレンなどのビニル高分子エラストマー、酢酸ビニル/ラウリン酸ビニル、酢酸ビニル/ステアリン酸ビニル、エチレン/酢酸ビニル、ポリビニルアルコールなどのビニル共重合エラストマー、またはそれらの混合物からなる群から選択される合成成分、および/または
b)チクル、チキバル、クラウンガム、グッタハンカン、マサランデュババラタ、マサランデュバチョコレート、ニスペロ、ロスディーニャ、ベネズエラチクル、ジェルトン、レチェサスピ、ペンダーレ、ペリロ、レチェデヴァカ(leche de vaca)、ニガーグッタ、ツノ、チルテ、および天然ゴムからなる群から選択される天然成分
を含む、請求項2に記載の歯科治療製品。
The gum base is
a) Butadiene-styrene rubber, isobutylene-isoprene copolymer, paraffin, petroleum-based (way), petroleum wax synthesis, polyisobutylene polyvinyl acetate, polyisobutadiene and isobutylene-isoprene copolymer, polybutene, polybutadiene and polyisobutylene, etc. low molecular weight elastomers, vinyl polymer elastomers such as polyvinyl acetate, polyethylene, vinyl copolymer elastomers such as vinyl acetate/vinyl laurate, vinyl acetate/vinyl stearate, ethylene/vinyl acetate, polyvinyl alcohol, or mixtures thereof. and/or b) Chicle, Chiquibal, Crown Gum, Gutta Hankan, Masaranduba Balata, Masaranduba Chocolate, Nispero, Rosdinha, Venezuelan Chicle, Jelutong, Lechesaspi, Pendare, Perillo, Leche de Vaca ( 3. A dental treatment product according to claim 2, comprising natural ingredients selected from the group consisting of: leche de vaca), niger gutta, horn, chirte, and natural gum.
ゼラチン、ペクチン、卵白、レシチン、マルチトール/ソルビトールまたはデンプンを含む、請求項から3のいずれか一項に記載の歯科治療製品。 Dental treatment product according to any one of claims 1 to 3, comprising gelatin, pectin, egg white, lecithin, maltitol/sorbitol or starch. 自己組織化ペプチドの濃度が、0.1-5000mg/kg、好ましくは約5-15mg/kgである、請求項1から4のいずれか一項に記載の歯科治療製品。 Dental treatment product according to any one of claims 1 to 4 , wherein the concentration of the self-assembling peptide is 0.1-5000 mg/kg, preferably about 5-15 mg/kg. 前記ペプチドが配列番号22の配列を含む、請求項1からのいずれか一項に記載の歯科治療製品。 6. A dental care product according to any one of claims 1 to 5 , wherein the peptide comprises the sequence SEQ ID NO:22. 前記自己組織化ペプチドが、配列番号1、3または20の配列の1つに対して少なくとも80%の配列同一性を有する配列を含み、好ましくは、前記ペプチドが配列番号1の配列を含む、請求項1から6のいずれか一項に記載の歯科治療製品。 1, 3 or 20; preferably, the self-assembling peptide comprises a sequence having at least 80% sequence identity to one of the sequences SEQ ID NO. The dental treatment product according to any one of Items 1 to 6 . 少なくとも0.1μmのサイズを有する0.4重量%以上のミネラル粒子を含まない、請求項1から7のいずれか一項に記載の歯科治療製品であって、
ここで、所望により、該歯科治療製品は、
a)キシリトール、エリスリトールおよびソルビトールを含む群から選択されるポリオール、
b)炭酸カルシウムおよびリン酸塩を含み、MOSH硬度が3未満である群から選択される塩、
c)ピロリン酸塩、および
d)pH制御剤
を含む群から選択される少なくとも1つのさらなる成分を含む、歯科治療製品。
Dental treatment product according to any one of claims 1 to 7, comprising no more than 0.4% by weight of mineral particles having a size of at least 0.1 μm,
Here, if desired, the dental treatment product comprises:
a) a polyol selected from the group comprising xylitol, erythritol and sorbitol;
b) a salt selected from the group comprising calcium carbonate and phosphate and having a MOSH hardness of less than 3;
A dental treatment product comprising at least one further ingredient selected from the group comprising: c) pyrophosphate; and d) a pH control agent.
請求項1からのいずれか一項の歯科治療製品を調製するための方法であって、以下の工程
a)組織化した自己組織化ペプチドのマトリックスを提供すること、
b)薬学的に許容される基、好ましくはガムベースを提供すること、ここで、工程a)およびb)は任意の順序で実行することができる、
c)組織化した自己組織化ペプチドのマトリックスおよび薬学的に許容される基剤を、所望により他の成分と一緒に、均質化すること、
d)歯科治療製品を形成すること、および
e)所望により、歯科治療製品を包装すること
を含む、方法。
9. A method for preparing a dental treatment product according to any one of claims 1 to 8 , comprising the steps of: a) providing a matrix of organized self-assembling peptides;
b) providing a pharmaceutically acceptable base , preferably a gum base, wherein steps a) and b) can be carried out in any order;
c) homogenizing the assembled self-assembling peptide matrix and the pharmaceutically acceptable carrier, optionally together with other ingredients;
d) forming a dental care product; and e) optionally packaging the dental care product.
請求項9の方法により入手可能な、請求項1-8のいずれか一項に記載の歯科治療製品。 Dental care product according to any one of claims 1-8, obtainable by the method of claim 9. 歯科治療製品を対象の口に経口投与することを含む、脱灰した歯を有する対象の歯の表面のさらなる脱灰を低減することにおける使用のための、請求項1-8および10のいずれか一項に記載の歯科治療製品であって、ここで好ましくは、該歯科治療製品は、口の中に少なくとも3分間維持されるものである、歯科治療製品。 Any of claims 1-8 and 10, for use in reducing further demineralization of a tooth surface in a subject having demineralized teeth, comprising orally administering a dental treatment product into the subject's mouth. A dental care product according to clause 1 , wherein preferably the dental care product is maintained in the mouth for at least 3 minutes. 対象が、口腔乾燥症、唾液分泌低下、歯ぎしり、象牙質知覚過敏症および/または酸侵食、所望により、唾液分泌低下に伴う酸侵食を含む群から選択される歯の再石灰化の減少に関連する疾患または状態を有する、請求項11に記載の使用のための歯科治療製品。 The subject is associated with a reduction in remineralization of teeth selected from the group comprising xerostomia, hyposalivation, bruxism, dentin hypersensitivity and/or acid erosion, optionally acid erosion associated with hyposalivation. 12. A dental care product for use according to claim 11 with a disease or condition. 歯科治療製品が対象により咀嚼されるものであり、好ましくは5分間の咀嚼が唾液の流れを少なくとも10倍増加させる、請求項11または12のいずれか一項に記載の使用のための歯科治療製品。 Dental care product for use according to any one of claims 11 or 12, wherein the dental care product is chewed by the subject, preferably chewing for 5 minutes increases salivary flow by at least 10 times. . 咀嚼時に、ガムベースが、歯の表面を洗浄し、組織化した自己組織化ペプチドのマトリックスが、歯の表面に歯の表面のさらなる脱灰を低減または防止するフィルムを提供する、請求項11-13のいずれか一項に記載の使用のための歯科治療製品。 11-13, wherein upon chewing, the gum base cleans the tooth surface and the matrix of organized self-assembling peptides provides a film on the tooth surface that reduces or prevents further demineralization of the tooth surface. A dental care product for use as described in any one of the following. 前記歯科治療製品は、齲蝕の発生率を低減する、請求項11-14のいずれか一項に記載の使用のための歯科治療製品。 Dental care product for use according to any one of claims 11-14, wherein the dental care product reduces the incidence of dental caries.
JP2022533500A 2019-12-04 2020-12-04 Personal dental care products to prevent demineralization Pending JP2023505248A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19213470.8A EP3831360A1 (en) 2019-12-04 2019-12-04 Personal dental care product for preventing demineralisation
EP19213470.8 2019-12-04
PCT/EP2020/084650 WO2021110923A1 (en) 2019-12-04 2020-12-04 Personal dental care product for preventing demineralisation

Publications (2)

Publication Number Publication Date
JP2023505248A JP2023505248A (en) 2023-02-08
JPWO2021110923A5 true JPWO2021110923A5 (en) 2023-12-11

Family

ID=68771460

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533500A Pending JP2023505248A (en) 2019-12-04 2020-12-04 Personal dental care products to prevent demineralization

Country Status (12)

Country Link
US (1) US20220387269A1 (en)
EP (2) EP3831360A1 (en)
JP (1) JP2023505248A (en)
KR (1) KR20220110200A (en)
CN (1) CN114929190A (en)
AU (1) AU2020397227A1 (en)
BR (1) BR112022009830A2 (en)
CA (1) CA3153103A1 (en)
CO (1) CO2022007809A2 (en)
IL (1) IL292741A (en)
MX (1) MX2022004694A (en)
WO (1) WO2021110923A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115968808B (en) * 2022-12-30 2023-11-03 江苏欢欢宠物食品有限公司 Processing technology of stamped bone dog chews

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US21A (en) 1836-09-05 Granite-machine for dressing or hammering
US9511A (en) 1852-12-28 Improvement in d aguerreotypi ng
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
WO2006127618A2 (en) 2005-05-23 2006-11-30 Cadbury Adams Usa Llc Compressible gum based delivery systems for the release of ingredients
US7399831B2 (en) 2004-10-25 2008-07-15 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
AU2005323062A1 (en) 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
US8299032B2 (en) 2005-06-27 2012-10-30 Menicon Co., Ltd. Self-assembling peptide and gel produced from the same
CA2654325A1 (en) 2006-06-16 2007-12-21 Gumlink A/S Chewing gum comprising a hydrophobic enzyme formulation
WO2008121447A1 (en) 2007-02-14 2008-10-09 Northwestern University Self-assembling membranes and related methods thereof
US9415084B2 (en) 2007-03-14 2016-08-16 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
CN101939329A (en) 2007-08-30 2011-01-05 滑铁卢大学 Amino acid pairing-based self assembling peptides and methods
MY154018A (en) 2008-02-08 2015-04-30 Colgate Palmolive Co Dental floss
EP2331743B1 (en) 2008-08-13 2013-07-10 Dow Global Technologies LLC Peptide-coated fibers
RU2011118341A (en) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) AGENT FOR OCCLUSION OF TISSUES
EP2757108B1 (en) 2009-03-09 2016-08-31 Menicon Co., Ltd. Self-assembling peptide and peptide gel with high strength
US20110117195A1 (en) 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
WO2013050432A2 (en) 2011-10-05 2013-04-11 Multi Oral Bv Method for oral care
EP2698162A1 (en) 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
US20140271985A1 (en) 2013-03-14 2014-09-18 Intercontinental Great Brands Llc Chewing gum snacks; and methods of making thereof
GB201306338D0 (en) * 2013-04-08 2013-05-22 Univ Leeds Novel proteoglycans
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
JP6649251B2 (en) * 2013-09-25 2020-02-19 クレデンティス・アクチェンゲゼルシャフトCredentis AG Dental care products for whitening teeth
EP3248591A1 (en) 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
EP3248590A1 (en) * 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
EP3284477A1 (en) * 2016-08-16 2018-02-21 Credentis AG Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis
MX2018003438A (en) * 2018-03-21 2019-09-23 Univ Mexico Nac Autonoma Dental enamel regenerator synthetic peptide.

Similar Documents

Publication Publication Date Title
JP5437574B2 (en) Tobacco alkaloid releasing chewing gum
JP4750127B2 (en) How to bring quick relief to nicotine chewing gum users
JP4283540B2 (en) Method for producing chewing gum in one step
JP2008515407A (en) Confectionery products
JP5133499B2 (en) Resin-adjusted compression molding chewing gum
JP5437692B2 (en) Chewing gum composition, chewing gum product, and methods for producing them
US6645535B2 (en) Method of making coated chewing gum products containing various antacids
CA2358490A1 (en) Anti-plaque emulsions and products containing same
JP4267830B2 (en) Mouth protection chewing gum and confectionery
TWI359679B (en) Antiplaque confectionery dental composition
JPWO2021110923A5 (en)
US20220387269A1 (en) Pesonal dental care product for preventing demineralisation
EP1693086A1 (en) Multi functional oral care chewing gum
WO2011089395A1 (en) Antiseptic chewing gum
WO2003092591A2 (en) Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
US11723918B2 (en) Solid pharmaceutical tablet
US11110045B2 (en) Oral compositions
WO1994006418A1 (en) A chewable composition comprising coenzyme q 10
WO2024081926A2 (en) Oral compositions
RU2347367C1 (en) Confectioner's product
WO2003092661A1 (en) Multi-phasic delivery via transmucosal absorption of appetite suppressants and craving reduction medicaments
JP2011057701A (en) Method to give rapid alleviation for nicotine chewing gum user
AU2003238540A1 (en) Protein based oral lubricant